05.12.2016 21:23:00
|
Morrison & Foerster Advises A-share Listed Shanghai Dazhong In HK$1.7 Billion H-share IPO
HONG KONG, Dec. 5, 2016 /PRNewswire/ -- Morrison & Foerster's Hong Kong capital markets team is representing Shanghai Dazhong Public Utilities (Group) Co., Ltd. in relation to its HK$1.7 billion H-share initial public offering (IPO), which listed today on the Hong Kong Stock Exchange.
Shanghai Dazhong is a leading public utility service provider in Shanghai that complements its operations with strategic and financial investments in its associated companies in public utility and other industries. It is the largest gas supplier in Shanghai, and is also an A-share listed company on the Shanghai Stock Exchange. Shanghai Dazhong will use most of the proceeds for expansion, including investment in gas supply businesses and acquisition of gas suppliers.
Ven Tan, managing partner of Morrison & Foerster's Hong Kong office and head of the Hong Kong capital markets team, led the deal team, which also included Of Counsels Samuel Ng and Wang Yu.
"We continue to see a steady stream of A-share listed companies coming to Hong Kong for a dual listing to extend their global reach. We are fortunate to have represented Shanghai Dazhong in its dual listing in Hong Kong and add them to our growing list of dual-listed clients which include China CNR, Angang Steel, Shanghai Petrochemical, Fosun Pharma, China CITIC Bank, Dalian Port and Goldwind. We see this growing client base as an important source for compliance work and other outbound transactional deals," said Mr. Tan.
Morrison & Foerster is one of the leading capital markets firms in Hong Kong, as well as Greater China. The most respected ranking publications, such as Chambers Global, Chambers Asia, IFLR, and Asia-Pacific Legal 500, have consistently ranked the firm highly for its premier capital markets offerings. Prior to this IPO, Morrison & Foerster's Hong Kong capital markets team most recently completed the HK$650 million IPO by Jacobson Pharma Corporation Limited, the largest generic drug company in Hong Kong, on the Hong Kong Stock Exchange.
ABOUT MOFO
We are Morrison & Foerster — a global firm of exceptional credentials. Our clients include some of the largest financial institutions, investment banks, Fortune 100, and technology and life sciences companies. The Financial Times has named the firm to its lists of most innovative law firms in Northern America and Asia every year that it has published its Innovative Lawyers Reports in those regions. In the past few years, Chambers USA has honored MoFo's Bankruptcy and IP teams with Firm of the Year awards, the Corporate/M&A team with a client service award, and the firm as a whole as Global USA Firm of the Year. Our lawyers are committed to achieving innovative and business-minded results for our clients, while preserving the differences that make us stronger.
Amy Merriweather, Sr. Public Relations Manager
(415) 268-6063, amerriweather@mofo.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/morrison--foerster-advises-a-share-listed-shanghai-dazhong-in-hk17-billion-h-share-ipo-300373024.html
SOURCE Morrison & Foerster
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!